Jan B. Egan

3.0k total citations · 1 hit paper
34 papers, 1.6k citations indexed

About

Jan B. Egan is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Jan B. Egan has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Pathology and Forensic Medicine and 11 papers in Cancer Research. Recurrent topics in Jan B. Egan's work include Cancer Genomics and Diagnostics (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (6 papers). Jan B. Egan is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (6 papers). Jan B. Egan collaborates with scholars based in United States, Germany and Malaysia. Jan B. Egan's co-authors include Esteban Braggio, A. Keith Stewart, Rafaël Fonseca, P. Leif Bergsagel, John D. Carpten, Jonathan J. Keats, Scott Van Wier, Victoria M. Garbitt, Marta Chesi and Yan W. Asmann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Jan B. Egan

33 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clonal competition with alternating dominance in multiple myeloma

2012 456 citations Jonathan J. Keats, Marta Chesi et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan B. Egan United States	16	868	709	448	436	272	34	1.6k
Rodney R. Miles United States	19	613 0.7×	252 0.4×	491 1.1×	460 1.1×	179 0.7×	68	1.4k
Carmen Chillón Spain	25	715 0.8×	793 1.1×	387 0.9×	308 0.7×	233 0.9×	76	1.5k
Mikael Behrendtz Sweden	22	679 0.8×	639 0.9×	271 0.6×	123 0.3×	183 0.7×	40	1.6k
Eija Mahlamäki Finland	19	781 0.9×	383 0.5×	641 1.4×	187 0.4×	417 1.5×	35	1.7k
Pascale Cornillet‐Lefèbvre France	23	793 0.9×	931 1.3×	313 0.7×	221 0.5×	236 0.9×	49	2.0k
Henrik Lilljebjörn Sweden	22	588 0.7×	673 0.9×	338 0.8×	124 0.3×	264 1.0×	51	1.6k
Edward J. Lee United States	17	421 0.5×	858 1.2×	500 1.1×	155 0.4×	127 0.5×	27	1.6k
F Viguié France	21	861 1.0×	844 1.2×	302 0.7×	136 0.3×	206 0.8×	45	1.6k
Dario Ferrero Italy	25	872 1.0×	1.0k 1.4×	472 1.1×	247 0.6×	98 0.4×	92	2.0k
Akihide Yoshimi Japan	23	994 1.1×	683 1.0×	231 0.5×	103 0.2×	244 0.9×	64	1.6k

Countries citing papers authored by Jan B. Egan

Since Specialization

Citations

This map shows the geographic impact of Jan B. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan B. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan B. Egan more than expected).

Fields of papers citing papers by Jan B. Egan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan B. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan B. Egan. The network helps show where Jan B. Egan may publish in the future.

Co-authorship network of co-authors of Jan B. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Jan B. Egan. A scholar is included among the top collaborators of Jan B. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan B. Egan. Jan B. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farina, Juan, Rory J. Olson, Radhika Dhamija, et al.. (2024). The Complexity of Familial Inheritance in Pectus Excavatum: A Ten-Family Exome Sequencing Analysis. Genes. 15(11). 1429–1429.

Vélez, Miguel González, Heidi Kosiorek, Jan B. Egan, et al.. (2021). Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer. Prostate Cancer and Prostatic Diseases. 25(3). 479–483. 30 indexed citations

Bogenberger, James M., Amro M. Abdelrahman, Jennifer L. Leiting, et al.. (2020). Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer. Cancer Chemotherapy and Pharmacology. 85(6). 1063–1078. 12 indexed citations

Wang, Junwen, Aleksandar Sekulić, Jan B. Egan, et al.. (2019). Somatic selection distinguishes oncogenes and tumor suppressor genes. Bioinformatics. 36(6). 1712–1717. 23 indexed citations

Bryce, Alan H., Jan B. Egan, James B. Smadbeck, et al.. (2019). Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing. Scientific Reports. 9(1). 3586–3586. 5 indexed citations

Yokoda, Raquel T., Bolni Marius Nagalo, Jan B. Egan, et al.. (2018). Oncolytic virotherapy in upper gastrointestinal tract cancers. PubMed. Volume 7. 13–24. 13 indexed citations

Yokoda, Raquel T., Bolni Marius Nagalo, Brent L. Vernon, et al.. (2017). Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect. PubMed. Volume 6. 39–49. 36 indexed citations

Braggio, Esteban, Scott Van Wier, Juhi Ojha, et al.. (2015). Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. Clinical Cancer Research. 21(17). 3986–3994. 150 indexed citations

Kortüm, K. Martin, Christian Langer, Jorge Monge, et al.. (2015). Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P). Annals of Hematology. 94(7). 1205–1211. 36 indexed citations

10.

Liang, Winnie S., Jessica Aldrich, Sara Nasser, et al.. (2014). Simultaneous Characterization of Somatic Events and HPV-18 Integration in a Metastatic Cervical Carcinoma Patient Using DNA and RNA Sequencing. International Journal of Gynecological Cancer. 24(2). 1–10. 17 indexed citations

11.

Egan, Jan B., Michael T. Barrett, Mia D. Champion, et al.. (2014). Whole Genome Analyses of a Well-Differentiated Liposarcoma Reveals Novel SYT1 and DDR2 Rearrangements. PLoS ONE. 9(2). e87113–e87113. 15 indexed citations

12.

Schmidt, Jessica, Esteban Braggio, K. Martin Kortuem, et al.. (2013). Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276. Leukemia. 27(12). 2357–2365. 122 indexed citations

13.

Braggio, Esteban, Brian Patrick O’Neill, Scott Van Wier, et al.. (2013). The Genomic Landscape Of Primary Central Nervous System Lymphomas. Blood. 122(21). 504–504. 1 indexed citations

14.

Keats, Jonathan J., Marta Chesi, Jan B. Egan, et al.. (2012). Clonal competition with alternating dominance in multiple myeloma. Blood. 120(5). 1067–1076. 456 indexed citations breakdown →

15.

Egan, Jan B., Chang-Xin Shi, Waibhav Tembe, et al.. (2012). Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood. 120(5). 1060–1066. 286 indexed citations

16.

Schmidt, Jessica, Esteban Braggio, Marta Chesi, et al.. (2012). Genome Wide Studies in Multiple Myeloma Identify XPO1/CRM-1 As a Critical Target Validated Using the Selective Inhibitor of Nuclear Export (SINE) KPT-276. Blood. 120(21). 573–573. 2 indexed citations

17.

Egan, Jan B., Patricia A. Thompson, Erin L. Ashbeck, et al.. (2010). Genetic Polymorphisms in Vitamin D Receptor VDR/RXRA Influence the Likelihood of Colon Adenoma Recurrence. Cancer Research. 70(4). 1496–1504. 40 indexed citations

18.

Hibler, Elizabeth A., Peter W. Jurutka, Jan B. Egan, et al.. (2010). Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites. The Journal of Steroid Biochemistry and Molecular Biology. 121(1-2). 438–441. 31 indexed citations

19.

Haussler, Mark R., Carol A. Haussler, G. Kerr Whitfield, et al.. (2010). The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging. The Journal of Steroid Biochemistry and Molecular Biology. 121(1-2). 88–97. 134 indexed citations

20.

Egan, Jan B., Patricia A. Thompson, Leonid Bartik, et al.. (2009). Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate β‐catenin activity in colon cancer cells. Molecular Carcinogenesis. 49(4). 337–352. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact